HemosIL HIT-Ab(PF4-H) is an on-demand, fully automated assay for HIT antibody detection on hemostasis testing systems. IL said that, unlike existing manual processes, HemosIL HIT-Ab(PF4-H) assay is liquid and ready-to-use, provides results in minutes and is available 24 hours/day, 7 days/week.
IL said that the assay is designed exclusively for the ACL TOP Family of Hemostasis Testing Systems ensuring simplicity and efficiency throughout the testing process.
Giovanni Russi, director of worldwide marketing of hemostasis reagents at IL, said: “Rapid detection of HIT antibodies is critical in the management of Heparin-treated patients suspected of HIT. HemosIL HIT-Ab(PF4-H) assay provides fast and accurate HIT antibody detection to inform therapeutic decisions when time is critical.
“This assay provides significant new efficiencies for our ACL TOP customers in Europe, where, until now, HIT antibody testing has been prohibitively labor-intensive and costly; and, most importantly, it will contribute to enhanced patient care.”
